Xueming Huang Selected Research

Xueming Huang Research Topics

2	Type 2 Diabetes Mellitus (MODY) 04/2022 - 11/2012
2	Reperfusion Injury 10/2013 - 11/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2022
1	Hemorrhage 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Neoplasms (Cancer) 07/2017
1	Acute Kidney Injury (Acute Renal Failure) 11/2012
1	Brain Ischemia (Cerebral Ischemia) 11/2012
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2012
1	Inflammation (Inflammations) 08/2010
1	Body Weight (Weight, Body) 04/2006
1	Obesity 04/2006
1	Hepatocellular Carcinoma (Hepatoma) 10/2005
1	Infections 10/2005

2	Pioglitazone (Actos)FDA Link 10/2013 - 11/2012
1	Transfer RNA (tRNA)IBA 04/2022
1	Mitochondrial DNA (mtDNA)IBA 04/2022
1	Tyrosine (L-Tyrosine)FDA Link 04/2022
1	Messenger RNA (mRNA)IBA 04/2022
1	ferric chlorideIBA 01/2019
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2019
1	AnticoagulantsIBA 01/2019
1	MAA868IBA 01/2019
1	Phosphotransferases (Kinase)IBA 07/2017
1	tyrosine receptor (receptor, tyrosine)IBA 07/2017
1	AntioxidantsIBA 10/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2012
1	Oxidants (Oxidizing Agents)IBA 11/2012
1	NF-kappa B (NF-kB)IBA 08/2010
1	LanthanumIBA 08/2010
1	Fatty Acid Transport Proteins (Fatty Acid Transport Protein)IBA 04/2006
1	Bile Acids and Salts (Bile Acids)IBA 04/2006
1	Glucose (Dextrose)FDA LinkGeneric 10/2005
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2005
1	Dual Specificity Phosphatase 1IBA 10/2005

1	Therapeutics 07/2017